Search results

Filters
Close
ADDED DATE
Added date
TOPICS Please select
WATCH / LISTEN / READ TIME
Joseph G Akar
Research Area(s) / Expertise:

Atrial Fibrillation

Electrophysiology & Arrhythmia

Atrial Arrhythmias
Personal History Dr Joseph Gabriel Akar was born in January 1971 and speaks Arabic, English and French.9 He is an Associate Professor of Medicine in the Section of Cardiology at the Yale University School of Medicine. He is currently Chief of Cardiac Electrophysiology and Director of the Electrophysiology Laboratory and the Complex Ablation Program at Yale-New Haven Hospital. … View more
MAPLE-HCM: Aficamten Outperforms Beta-Blocker in Obstructive Hypertrophic Cardiomyopathy
Added: 7 months ago Source:  Radcliffe Cardiology
Two phase 3 trials presented at the European Society of Cardiology Congress 2025 have provided new insights into the role of myosin inhibitors for hypertrophic cardiomyopathy (HCM), with one trial demonstrating superiority over standard care in obstructive HCM and another failing to meet its primary endpoints in the non-obstructive form of the disease.¹˒²The MAPLE-HCM trial found that the cardiac… View more

Guidelines & Statements

Heart Failure
Ep 139: The Genetic Revolution in HCM: Mapping Family Risk to Targeted Treatment
Added: 9 months ago
In this essential episode of Parallax, Dr Ankur Kalra is joined by Dr Carolyn Ho, Professor of Medicine at Harvard Medical School and Medical Director of the Cardiovascular Genetics Program at Brigham and Women's Hospital, for a comprehensive discussion on how genetic testing is reshaping hypertrophic cardiomyopathy management.The conversation explores the VANISH HCM trial results, which showed… View more

Demographic

Heart Failure
Ep 150: Building a Legacy in Cardiology: From the NIH to JAMA Cardiology with Robert Bonow
Added: 3 months ago
In this landmark 150th episode of Parallax marking the start of Season 8, Dr Ankur Kalra welcomes Dr Robert Bonow, Professor of Medicine and Cardiology at Northwestern University and Editor-in-Chief of JAMA Cardiology. This milestone conversation explores the career of one of cardiology's most influential academic leaders and examines how strategic vision, mentorship, and institutional leadership… View more

Guidelines & Statements

Heart Failure
Perry Elliott
Research Area(s) / Expertise: Job title: Director of UCL Institute of Cardiovascular Science and Professor of Cardiovascular Medicine
Professor Perry Mark Elliott was born on December 7, 1963, in London.6 He is a Professor of Cardiovascular Medicine at University College London (UCL) and a Senior Investigator of the UK National Institute for Health Research (NIHR).He is Director of the UCL Centre for Heart Muscle Disease, Head of Clinical Research at the Institute of Cardiovascular Science UCL and a consultant cardiologist in… View more
Kenneth Ellenbogen
Research Area(s) / Expertise: Job title: Professor and Chair, Division of Cardiology
Personal HistoryProf Kenneth A. Ellenbogen is a full Professor of Medicine (Cardiology) and Director of Clinical Cardiac Electrophysiology and Pacing at the Virginia Commonwealth University School of Medicine.He is a native of New York and speaks both English and French.3, 4Academic HistoryProf Ellenbogen obtained his undergraduate degree from Princeton University in 1976, where he graduated… View more
Eugene Braunwald
Research Area(s) / Expertise:

Cardiomyopathies

Heart Failure

 Job title: Distinguished Hersey Professor of Medicine, MACC
Personal History Dr Braunwald is an Austrian-born American cardiologist. He was born on August 15, 1929 to Jewish parents and moved to the United States in 1939.1, 3 “I had an idyllic childhood there with an excellent school and tutors in English and piano,” he says.6 He has a younger brother who became a haematologist.1 Music is one of Dr Braunwald’s passions. He is also a keen traveler:… View more
Acoramidis Efficacy in ATTR-CM Genotypes
Added: 5 months ago Source:  Radcliffe Cardiology
New analyses from the ATTRibute-CM trial show that the transthyretin (TTR) stabiliser acoramidis provides consistent clinical benefits in patients with both wild-type (ATTRwt-CM) and variant (ATTRv-CM) transthyretin amyloid cardiomyopathy.1 The findings include data from the main 30-month trial and its ongoing 42-month open-label extension (OLE).Acoramidis is an orally administered, small… View more

Inherited and Congenital Cardiac Conditions

Heart Failure
Added: 3 months ago Source:  Radcliffe Cardiology
A novel cardiac myosin agonist, danicamtiv, has shown favourable safety and efficacy signals in patients with dilated cardiomyopathy (DCM), particularly in those with specific genetic variants, according to results from a phase 2a open-label trial.¹ Precision therapies for DCM are currently lacking, despite its diverse clinical manifestations often linked to underlying genetic causes.²Danicamtiv… View more

Imaging & Diagnostics

Inherited and Congenital Cardiac Conditions
Pathophysiology, Mechanism, Diagnosis and Management of PAH
Author(s): Apoorva Gangavelli , Ronaldo C Fabiano , Mariam Riad , et al Added: 3 months ago

Prevention & Chronic Conditions